Seelos Therapeutics Inc (SEEL)
3.90
-1.10
(-22.00%)
USD |
NASDAQ |
Sep 27, 16:00
3.83
-0.07
(-1.79%)
After-Hours: 20:00
Seelos Therapeutics Research and Development Expense (Annual): 30.12M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.12M |
| December 31, 2022 | 58.62M |
| December 31, 2021 | 46.65M |
| December 31, 2020 | 10.98M |
| December 31, 2019 | 22.56M |
| December 31, 2018 | 1.22M |
| December 31, 2017 | 3.463M |
| December 31, 2016 | 5.88M |
| December 31, 2015 | 14.65M |
| December 31, 2014 | 21.29M |
| December 31, 2013 | 5.123M |
| December 31, 2012 | 5.375M |
| December 31, 2011 | 5.821M |
| December 31, 2010 | 2.11M |
| Date | Value |
|---|---|
| December 31, 2009 | 1.884M |
| December 31, 2008 | 5.410M |
| December 31, 2007 | 5.023M |
| December 31, 2006 | 5.425M |
| December 31, 2005 | 11.22M |
| December 31, 2004 | 10.68M |
| December 31, 2003 | 8.439M |
| December 31, 2002 | 21.62M |
| December 31, 2001 | 12.46M |
| December 31, 2000 | 6.892M |
| December 31, 1999 | 2.374M |
| December 31, 1998 | |
| December 31, 1997 | 2.078M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
10.98M
Minimum
2020
58.62M
Maximum
2022
33.79M
Average
30.12M
Median
2023
Research and Development Expense (Annual) Benchmarks
| 180 Life Sciences Corp | 2.784M |
| Cassava Sciences Inc | 89.42M |
| Cara Therapeutics Inc | 108.51M |
| Citius Pharmaceuticals Inc | 14.82M |
| Moleculin Biotech Inc | 19.49M |